Skip Navigation



Carcinogenesis Advance Access published online on February 25, 2006

Carcinogenesis, doi:10.1093/carcin/bgi371
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
27/8/1636    most recent
bgi371v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Moussavi, M.
Right arrow Articles by Salh, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moussavi, M.
Right arrow Articles by Salh, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org
Received September 9, 2005
Revised January 14, 2006
Accepted February 11, 2006

MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

Curcumin mediates ceramide generation via the de novo pathway in colon cancer cells

Maryam Moussavi 1, Kiran Assi 1, Antonio Gómez-Muñoz 2, and Baljinder Salh 1 *

1 The Jack Bell Research Centre, 2660 Oak Street, and Vancouver, BC, Canada
2 Current address: Department of Biochemistry and Molecular Biology, Faculty of Science, University of the Basque Country, P. O. Box 644, 48080 Bilbao, Spain

* To whom correspondence should be addressed.
Baljinder Salh, E-mail: bsalh{at}interchange.ubc.ca


   Abstract

A wealth of evidence supports the notion that curcumin, a phytochemical present in turmeric, is a potent chemopreventive agent for colon cancer. Its mechanism of action remains incompletely understood. Here we report that curcumin's apoptosis-inducing effects in colon cancer cell lines is accompanied by robust ceramide generation. This occurs through de novo synthesis as the increase in ceramide could be attenuated by pre-incubation of the cells with myriocin, and no changes were observed in sphingomyelin levels, or in either acidic or neutral sphingomyelinase activities. Furthermore, cell death could in part be reversed by myriocin, indicating, for the first time, that endogenous ceramide generation by this agent contributes towards its biological activity. We then investigated the role of reactive oxygen species (ROS) in this phenomenon and demonstrated that curcumin induced robust oxidant generation in the cell lines tested, and its reversal by N-acetylcysteine, completely attenuated apoptosis. We next confirmed that curcumin could activate c-jun N-terminal kinase (JNK) and that its modulation could reverse cell death, however this intervention could not block ceramide generation, or ROS production. Conversely however, inhibition of ROS using N-acetylcysteine led to an inhibition of JNK activation. Hence we conclude that curcumin induces apoptosis via a ROS-associated mechanism that converges on JNK activation, and to a lesser extent via a parallel ceramide-associated pathway.

Keywords: Curcumin; Ceramide; JNK; ROS; Apoptosis.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
R. Kamath, Z. Jiang, G. Sun, J. C. Yalowich, and R. Baskaran
c-Abl Kinase Regulates Curcumin-Induced Cell Death through Activation of c-Jun N-Terminal Kinase
Mol. Pharmacol., January 1, 2007; 71(1): 61 - 72.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.